$6.69
0.192.92%
Pre-Market: Dec 20, 4:01 PM EDT
Redhill Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Redhill Biopharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2022 | 2022-06-23 | $-300.00 | $-230.00 | -30.4 % |
Dec 2021 | 2022-03-17 | $-500.00 | $-330.00 | -51.5 % |
Sep 2021 | 2021-11-30 | $-500.00 | $-210.00 | -138.1 % |
Jun 2021 | 2021-08-26 | $-60.00 | $-120.00 | 50.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2023 | 2023-04-28 | $12.80M | $18.10M | -29.3 % |
Mar 2022 | 2022-06-23 | $18.24M | $24.30M | -24.9 % |
Dec 2021 | 2022-03-17 | $22.07M | $24.08M | -8.34 % |
Sep 2021 | 2021-11-30 | $21.61M | $24.52M | -11.9 % |
Redhill Biopharma (RDHL) is scheduled to report earnings on January 3, 2025. The last reported earnings were for reported on August 29, 2024 for H1.
The Actual EPS was $0.00, which hit the estimate of $0.00.
The Actual Revenue was $2.6M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.